KeyBanc Capital Markets has downgraded Nike to Sector Weight from Overweight, citing a slower-than-anticipated turnaround and a confluence of geographic and marketplace pressures that increase near-term uncertainty for the sportswear giant.
Analyst Ashley Owens, who upgraded the stock in September, noted that some elements of that prior thesis remain intact - in particular, North American growth and work to rebuild the wholesale channel. However, Owens said progress on rightsizing Nike's sportswear operations and addressing persistent weakness in Greater China has been slower than the firm expected.
Those China challenges now factor more heavily into KeyBanc's outlook. The firm reduced its fiscal 2027 revenue estimate for Nike to $46.17 billion from $46.46 billion, reflecting steeper declines in Greater China, which it now forecasts down 12% year-on-year compared with a prior estimate of -9.3%. KeyBanc also pared expected EPS to $1.74 from $1.79. The revised estimates sit roughly 1-4% below consensus, according to the firm.
Owens also pointed to a reversal in trends across EMEA as another source of concern. She said the company's turnaround initiatives are taking longer than expected to show results, a dynamic that is compounded by uncertainty in China and EMEA, ongoing marketplace headwinds, and yet another management transition.
The analyst highlighted a broader competitive dynamic as well. While Nike's brand health remains strong in consumer surveys, Owens observed that shoppers are increasingly spreading purchases across multiple brands rather than remaining loyal to Nike alone. That shift - with market share moving toward so-called "disruptor" brands - is expected to prolong the road to recovery and extend the timeframe for marketplace adjustments.
Event-level opportunities have also failed to create the intended differentiation. KeyBanc noted that the World Cup, which had been viewed as a potential catalyst, did not deliver unique upside for Nike. The widespread industry adoption of pink boots by multiple manufacturers - including Nike, Adidas, Puma, New Balance, and Skechers - blurred the product distinction that Nike had sought from tournament-linked offerings.
The firm further flagged management turnover as a complicating factor. Nike announced this week that CFO Matthew Friend will be succeeded in August by David Denton, the former CFO of Pfizer. KeyBanc said the leadership change could prompt additional cleanup actions that are not yet reflected in estimates and could affect the timing of events such as the company's planned Investor Day in the fall.
On valuation, KeyBanc noted that Nike is trading at roughly 22.7 times forward earnings - about a seven-turn premium to peers - a gap the analyst described as difficult to justify given muted growth and constrained upside potential from current levels.
Contextual takeaways
- KeyBanc lowered guidance for fiscal 2027 revenue and EPS amid worsening China declines and weaker EMEA performance.
- Competitive dynamics and product proliferation during the World Cup reduced expected differentiation for Nike's products.
- Management change at the CFO level introduces additional uncertainty and could prompt further actions that are not yet built into current estimates.